| Income Statement | 2025-07-31 | |||
|---|---|---|---|---|
| Research and development | 22,575 | |||
| General and administrative | 7,372 | |||
| Total operating expenses | 29,947 | |||
| Loss from operations | -29,947 | |||
| Interest income | 2,233 | |||
| Interest expense | 758 | |||
| Other expenses (income), net | -280 | |||
| Total other income, net | 1,195 | |||
| Net loss before income taxes | -28,752 | |||
| Provision for (recovery of) income taxes | 239 | |||
| Net loss | -28,991 | |||
| Unrealized loss (gain) on available-for-sale investments | -240 | |||
| Total comprehensive loss | -29,231 | |||
| Earnings per share, basic, total | 0.57 | |||
| Earnings per share, diluted, total | 0.57 | |||
| Weighted-average number of common shares used in net loss per share, basic | 51,097,711 | |||
| Weighted-average number of common shares used in net loss per share, diluted | 51,097,711 | |||
enGene Holdings Inc. (ENGNW)
enGene Holdings Inc. (ENGNW)